2.4% with placebo [10]
I feel really good and healthy
The FDA does not currently have guidelines on microdosing GLP-1 medications and its clear that more study is needed to understand the risks, benefits, and efficacy of doses that are lower than those recommended by current prescription guidelines
Request a call 5-minute readPublished 05/15/2026Updated 11:10 AM EST, 06/08/2026 Sources Medicare GLP-1 Bridge opens in new window , Medicare.gov, last accessed April 24, 2026
Truncated GLP-1 fragment comes into focus Having to hand the genetic sequences meant scientists could now chemically synthesise glucagon peptides they needed to unravel their biological function
The dataset included formal low blood pressure diagnoses, systolic blood pressure readings dropping below 90 mm Hg, new prescriptions for hypotension drugs, and sudden episodes of dizziness, lightheadedness, fainting, and physical falls